Anuh Pharma posts Rs 11.42 cr standalone profit in Q1FY27
An 8.40% operating margin was supplemented by Rs 3.08 cr of other income, while tax absorbed 32.51% of pre-tax profit.
Filed 07 Aug 2026, 18:03 IST · after market close · ANUHPHR (ANUHPHR)
Key takeaways
- Anuh Pharma reported standalone Q1FY27 net profit of Rs 11.42 cr on revenue of Rs 193.81 cr.
- Operating profit of Rs 16.29 cr resulted in an 8.40% operating margin, with no interest expense reported.
- Other income of Rs 3.08 cr supplemented pre-tax profit, while the 32.51% tax rate left EPS at Rs 1.14.
Operating profit set the base for Q1 earnings
Standalone revenue of Rs 193.81 cr converted into Rs 16.29 cr of operating profit, an 8.40% operating margin. After Rs 2.43 cr of depreciation, profit before tax stood at Rs 16.93 cr.
Other income supported profit beyond operations
Other income added Rs 3.08 cr to the quarter and was an additional contributor to pre-tax profit beyond operating earnings. The company reported no interest expense, while tax of Rs 5.50 cr reduced pre-tax profit to Rs 11.42 cr of net profit.
Results were filed after market close
The standalone results were filed on 7 August 2026 at 18:03 IST, after the market closed. There is no immediate market reaction to assess.
Q1FY27 at a glance
Standalone figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q1FY27 |
|---|---|
| Revenue | ₹194 cr |
| Other income | ₹3 cr |
| Expenses | ₹178 cr |
| Operating profit | ₹16 cr |
| Operating margin (%) | 8.40% |
| Interest | ₹0 cr |
| Depreciation | ₹2 cr |
| Profit before tax | ₹17 cr |
| Tax | ₹6 cr |
| Net profit | ₹11 cr |
| EPS (₹) | ₹1.14 |
What to watch
- Whether operating margin moves from 8.40% in the next reported quarter.
- Whether other income remains a contributor alongside operating profit of Rs 16.29 cr.
- Whether the tax rate moves from 32.51% and interest expense remains at Rs 0 cr.